Cyna Khalily, MD
Orthopaedic Surgery · Louisville, KYNPI 1003925074
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,982 of the $54,572 with a category attached, or 84.3%. Smith+Nephew accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $32,216 and has fallen 99.9% since, to $20 in 2024.
Across 63 payments — averaging $866.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$54K
- Engage Uni, LLC$114
- Johnson & Johnson$21
Across 3 payments — averaging $1027.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$3K
What the payments were for
- Consulting fees$45,98284%
- Speaking & faculty fees$1,8403%
- Travel & lodging$5,28410%
- Food & beverage$1,3522%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 61 | $54,437 |
| Engage Uni, LLC | 1 | $114 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$35,257
- LEGION TKS$28,496
- REAL INTELLIGENCE$5,617
- Legion$2,530
- Journey II XR$1,840
- Engage Partial Knee System$588
- Journey II CR$150
How this compares
$54,572 in reported general payments places this provider in the 85th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 79 | $520 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $459 |
| Diclofenac Sodium | 28 | $290 |
| Gabapentin | 39 | $187 |
| Meloxicam | 41 | $64 |
| Amoxicillin | 19 | $14 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Louisville
- Arthur MalkaniLouisville$9.6M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.5M
- Akbar NawabLouisville$1M
- Joseph GreeneLouisville$581K
- George QuillLouisville$304K
- Rodolfo Zamora RendichLouisville$292K
- Richard SweetLouisville$238K
- Frank BonnarensLouisville$146K
- Ryan EadsLouisville$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.